Chemical Compound Review:
AGN-PC-00K77H 2-[(3-amino-2-hydroxy-4- phenyl...
Synonyms:
CHEMBL1161364, SureCN8191715, NSC-265489, AC1L1FHH, AC1Q5SDE, ...
- Immunomodulatory and therapeutic properties of bestatin in mice. Talmadge, J.E., Lenz, B.F., Pennington, R., Long, C., Phillips, H., Schneider, M., Tribble, H. Cancer Res. (1986)
- Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes. Schorlemmer, H.U., Bosslet, K., Sedlacek, H.H. Cancer Res. (1983)
- The slow, tight binding of bestatin and amastatin to aminopeptidases. Wilkes, S.H., Prescott, J.M. J. Biol. Chem. (1985)
- Inhibition by bestatin of a mouse ascites tumor dipeptidase. Reversal by certain substrates. Patterson, E.K. J. Biol. Chem. (1989)
- Stimulation of cell-mediated immunity by bestatin correlates with reduction of bacterial persistence in experimental chronic Salmonella typhimurium infection. Dickneite, G., Kaspereit, F., Sedlacek, H.H. Infect. Immun. (1984)
- Effect of inhibition of neuropeptidases on the pain threshold of mice and rats. Carenzi, A., Frigeni, V., Reggiani, A., Della Bella, D. Neuropharmacology (1983)
- Effect of bestatin, an aminopeptidase inhibitor, on alcohol intake in alcohol-preferring P rats. Szczepanska, R., Harding, S., Grupp, L.A. Alcohol. Clin. Exp. Res. (1996)
- Characterization of the decline in alcohol consumption by aminopeptidase inhibition. Szczepanska, R., Harding, S., Grupp, L.A. Drug and alcohol dependence. (1996)
- Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin. Hiramatsu, M., Nabeshima, T., Fukaya, H., Furukawa, H., Kameyama, T. Eur. J. Pharmacol. (1986)
- Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells. Mishima, Y., Matsumoto-Mishima, Y., Terui, Y., Katsuyama, M., Yamada, M., Mori, M., Ishizaka, Y., Ikeda, K., Watanabe, J., Mizunuma, N., Hayasawa, H., Hatake, K. J. Natl. Cancer Inst. (2002)
- Leukotriene A4 hydrolase: mapping of a henicosapeptide involved in mechanism-based inactivation. Mueller, M.J., Wetterholm, A., Blomster, M., Jörnvall, H., Samuelsson, B., Haeggström, J.Z. Proc. Natl. Acad. Sci. U.S.A. (1995)
- Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis. Burley, S.K., David, P.R., Lipscomb, W.N. Proc. Natl. Acad. Sci. U.S.A. (1991)
- Synergistic Interactions of the Antiretroviral Protease Inhibitors Saquinavir and Ritonavir with Chloroquine and Mefloquine against Plasmodium falciparum In Vitro. Skinner-Adams, T.S., Andrews, K.T., Melville, L., McCarthy, J., Gardiner, D.L. Antimicrob. Agents Chemother. (2007)
- The antitumor effect of bleomycin combined with bestatin against Ehrlich ascites carcinoma in mice. Kaya, G., Akin, C., Altuğ, T., Devrim, S. Proc. Soc. Exp. Biol. Med. (1988)
- Successful chemoimmunotherapy of murine L1210 lymphatic leukemia with cyclophosphamide and mafosfamide-treated leukemia cells. Kawalec, M., Skórski, T., Kawiak, J. Investigational new drugs. (1988)
- Degradation of abnormal proteins in intact mouse reticulocytes: accumulation of intermediates in the presence of bestatin. Botbol, V., Scornik, O.A. Proc. Natl. Acad. Sci. U.S.A. (1979)
- Molecular cloning and functional expression of a Caenorhabditis elegans aminopeptidase structurally related to mammalian leukotriene A4 hydrolases. Baset, H.A., Ford-Hutchinson, A.W., O'Neill, G.P. J. Biol. Chem. (1998)
- An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2. Gonzalez, D.E., Covitz, K.M., Sadée, W., Mrsny, R.J. Cancer Res. (1998)
- Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. Robinson, M.B., Blakely, R.D., Couto, R., Coyle, J.T. J. Biol. Chem. (1987)
- A Ca2+-dependent autoregulation of lipopolysaccharide-induced IL-8 receptor expression in human polymorphonuclear neutrophils. Bhattacharya, C., Samanta, S., Gupta, S., Samanta, A.K. J. Immunol. (1997)
- Glucagon-(19-29), a Ca2+ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidase. Blache, P., Kervran, A., Dufour, M., Martinez, J., Le-Nguyen, D., Lotersztajn, S., Pavoine, C., Pecker, F., Bataille, D. J. Biol. Chem. (1990)
- Mechanism-based inactivation of leukotriene A4 hydrolase/aminopeptidase by leukotriene A4. Mass spectrometric and kinetic characterization. Orning, L., Gierse, J., Duffin, K., Bild, G., Krivi, G., Fitzpatrick, F.A. J. Biol. Chem. (1992)
- Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13. Bauvois, B., Puiffe, M.L., Bongui, J.B., Paillat, S., Monneret, C., Dauzonne, D. J. Med. Chem. (2003)
- Involvement of the 5-lipoxygenase/leukotriene A4 hydrolase pathway in 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors. Sun, Z., Sood, S., Li, N., Ramji, D., Yang, P., Newman, R.A., Yang, C.S., Chen, X. Carcinogenesis (2006)
- Phosphoramidon potentiates mammalian tachykinin-induced biting, licking and scratching behaviour in mice. Sakurada, T., Tan-No, K., Yamada, T., Sakurada, S., Kisara, K. Pharmacol. Biochem. Behav. (1990)
- Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions. Grujić, M., Renko, M. Cancer Lett. (2002)
- Bestatin, an inhibitor of aminopeptidases, provides a chemical genetics approach to dissect jasmonate signaling in Arabidopsis. Zheng, W., Zhai, Q., Sun, J., Li, C.B., Zhang, L., Li, H., Zhang, X., Li, S., Xu, Y., Jiang, H., Wu, X., Li, C. Plant Physiol. (2006)
- Aminopeptidase activity in human nasal mucosa. Ohkubo, K., Baraniuk, J.N., Hohman, R., Merida, M., Hersh, L.B., Kaliner, M.A. J. Allergy Clin. Immunol. (1998)
- Crystallization and preliminary X-ray crystallographic studies of recombinant human leukotriene A4 hydrolase complexed with bestatin. Tsuge, H., Ago, H., Aoki, M., Furuno, M., Noma, M., Miyano, M., Minami, M., Izumi, T., Shimizu, T. J. Mol. Biol. (1994)
- Cancer cell-targeted drug delivery utilizing oligopeptide transport activity. Nakanishi, T., Tamai, I., Takaki, A., Tsuji, A. Int. J. Cancer (2000)